Safety of calcium-channel blockers

Medical Letter on Drugs and Therapeutics

Volumn 39, Issue 994, 1997, Pages 13-14

  Abramowicz, Mark ^f   Rizack, Martin A ^a   Goodstein, Donna ^f   Faucard, Amy ^f   Hansten, Philip D ^b   Steigbigel, Neal H ^c   Nash, Ira S ^d   Smoller, Jordan W ^e   Zuccotti, Gianna ^c  

^a ROCKEFELLER UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALAT CC; AMLODIPINE; AMLODIPINE BESYLATE; BEPRIDIL; CALAN SR; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DYNACIRC CR; FELODIPINE; ISRADIPINE; NICARDIPINE; NIFEDIPINE; NIMODIPINE; NISOLDIPINE; UNCLASSIFIED DRUG; VERAPAMIL;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DRUG APPROVAL; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; HEART ARRHYTHMIA; HEART INFARCTION; HUMAN; HYPERTENSION; META ANALYSIS; MORTALITY; SHORT SURVEY; SIDE EFFECT; STROKE; SUDDEN DEATH; SUSTAINED RELEASE PREPARATION;

CALCIUM CHANNEL BLOCKERS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION;

EID: 1842331533     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Drugs of Choice from The Medical Letter, 1995, pages 5, 50 and 94
2. BM Psaty et al, JAMA, 274:620, 1995
3. CD Furberg et al, Circulation, 92:1326, 1995
4. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
5. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
6. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
7. NM Kaplan, Am J Cardiol, 78:932, 1996
8. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
9. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
10. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
11. NO Borhani et al, JAMA, 276:785, Sept 11, 1996
12. SH Cheeseman et al, J Acquir Immune Defic Syndr, 8:141, 1995
13. BM Psaty et al, JAMA, 274:620, 1995
14. CD Furberg et al, Circulation, 92:1326, 1995
15. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
16. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
17. M Pahor et al, Lancet, 348:493, 1996; M Pahor et al, Lancet, 347:1061, 1996; M Pahor et al, J Am Geriatr Soc, 43:1191, 1995
18. NM Kaplan, Am J Cardiol, 78:932, 1996
19. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
20. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
21. H Jick et al, Pharmacotherapy, 16:321, 1996; L Gong et al, J Hypertens, 14:1237, 1996; S Braun et al, J Am Coll Cardiol, 28:7, 1996
22. NO Borhani et al, JAMA, 276:785, Sept 11, 1996